Nicotinic Acid Xanthinol Glucoside Injection

This product is a xanthine vasodilator that can reduce peripheral vascular resistance, improve certain blood rheology indicators, promote glucose through the blood-brain barrier, and enhance brain cells' utilization of glucose and oxygen, thereby improving brain sugar metabolism and brain function.

7-[2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline nicotinate

This product is a colorless clear liquid.

Ischemic cerebrovascular disease, peripheral vascular circulation disorders.

Intravenous drip. Initial dose: 300 mg/day, gradually increased to 600 mg ~ 900 mg/day, once a day.

In the early stage of medication, some patients may experience facial flushing, dry mouth, chest tightness, rash, erythema and wheals on the limbs. Very few patients may experience cerebral hemorrhage and brain hernia.

1. Patients with acute myocardial infarction, hemorrhagic cerebrovascular disease, various acute bleeding, dehydration, mitral stenosis and obvious heart failure are prohibited from using this product. 2. Patients who are allergic to this product are prohibited from using this product.

It should not be used simultaneously with ganglionic blockers and sympathetic anti-drugs.

Keep in a light-proof and airtight container. The validity period is tentatively set at 24 months.

250ml: 0.3g nicotinic acid xanthinol and 12.5g glucose

Harbin Medisan Pharmaceutical Co., Ltd.

• Founded in:

  1996-06-21

• Address:

  Beijing Road, Limin Development Zone, Harbin

• Tax NO.:

  91230100607168790X

• Registered Funds:

  316.35755 million yuan

• Website:

  Log in to view

• Email:

  Log in to view